Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Bavarian Nordic Gains $9M Contract to Help Develop New Ebola Vaccine

September 16, 2015 8:10 am | News | Comments

The five-year base subcontract covers studies to improve the manufacturing process and establish long-term storage of MVA-BN Filo bulk vaccine. Read more...


An Amazon of Tumors

September 16, 2015 8:05 am | by Alex O'Brien, Mosaic | News | Comments

Oncologist Jim Olson has also created a new process for obtaining samples that bypasses the traditional, slow, bureaucratic procedure that could take months. Read more...


Mylan Launches Generic Unasyn for Injection

September 16, 2015 8:00 am | News | Comments

This is the generic version of Pfizer's Unasyn.


Preventing Crystallization to Improve Drug Efficiency

September 16, 2015 7:45 am | by Ecole Polytechnique Federale De Lausanne | News | Comments

An international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs. Read more...


Genetic Sleuthing

September 16, 2015 7:30 am | by Harvard Gazette | News | Comments

Scientists fighting last year’s outbreak of Ebola used the power of genetic sequencing to unlock the secrets of the deadly virus. Read more...


Mylan Opens $27.14B Hostile Bid for Perrigo

September 16, 2015 7:15 am | by The Associated Press | News | Comments

Perrigo's board had rejected several offers from Mylan and has said it is confident its shareholders would reject Mylan's offer. Read more...


Drug Prevents Type 1 Diabetes In Mice

September 15, 2015 11:45 am | by Stanford University | News | Comments

A compound that blocks the synthesis of hyaluronan, a substance generally found in in all body tissue, protected mice from getting Type 1 diabetes. The compound is already approved in Europe and Asia for the treatment of gallbladder disease. Read more...


XenoPort Shares Dive After Psoriasis Drug Study Results

September 15, 2015 11:34 am | by Stephanie Guzowski, Editor | News | Comments

Shares of Santa Clara, CA-based XenoPort were down 25 percent by midmorning Tuesday after the company announced positive preliminary results from a Phase 2 clinical trial of its oral psoriasis drug.  Although the biotech said it expects to begin Phase 3 trials of its drug, XP23829, in 2016, a high rate of gastrointestinal side effects may impede its efforts. Read more...


Repatha Reduced LDL-C by up to 75 Percent Compared With Placebo

September 15, 2015 9:30 am | News | Comments

Amgen Canada Inc. today announced that Health Canada has approved a new cholesterol-lowering medication, RepathaTM (evolocumab). Repatha is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol (LDL-C), or "bad" cholesterol, from the blood. Read more...


Crunching Numbers to Combat Cancer

September 15, 2015 9:23 am | by UC San Francisco | News | Comments

UC San Francisco has received a National Cancer Institute grant of $5 million over the next five years to lead a massive effort to integrate the data from all experimental models across all types of cancer. The web-based repository is an important step in moving the fight against cancer toward precision medicine. Read more...


Filling a Void in Stem Cell Therapy

September 15, 2015 9:14 am | by Harvard University | News | Comments

A new porous hydrogel could boost the success of stem-cell-based tissue regeneration. Read more...


Panel Backs Aspirin For Heart Health In Only Certain Adults

September 15, 2015 8:55 am | by Lauren Neergaard, AP Medical Writer | News | Comments

A government task force says a daily low-dose aspirin could help certain people in their 50s and 60s prevent a first heart attack or stroke - and they might get some protection against colon cancer at the same time. Read more...


Why MS Symptoms May Improve as Days Get Shorter

September 15, 2015 8:25 am | by Harvard University | News | Comments

For patients and clinicians alike, it’s long been a mystery: Why do symptoms of multiple sclerosis (MS) seem to get better in the winter and worse in the summer? A group at Brigham and Women’s Hospital (BWH) and collaborators have found an explanation that could lead to a deeper understanding of the disease and more targeted treatment options for patients.

FDA Accepts NDA for First-Ever Digital Medication

September 15, 2015 8:25 am | by Ryan Bushey, Associate Editor | News | Comments

This creation could provide significant assistance in helping to treat behavioral health conditions. Read more...


New Ebola Death Reported in Sierra Leone

September 15, 2015 7:55 am | News | Comments

The announcement marked another setback in ending Ebola transmission in Sierra Leone. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.